HIGHLIGHTS
- who: . and collaborators from the Shiraz University of Medical Sciences, Iran have published the Article: Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies, in the Journal: (JOURNAL) of 22/Dec/2021
- what: The authors focused on the use and monitoring of tacrolimus during NR therapy.
- future: Clinical studies are needed to better understand the optimal use of NR in this population. on current experience cyclosporine should be reduced to 20% of the baseline daily dose (DD) upon initiation of NR and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.